$PSID Just purely technically, the stock is printing an RSI around the low 30’s. Each time it has hit that type of mark over the past 18 months, upside force has ensued on the chart, including a 200% rip in May.
PSID, together with its subsidiaries, develops and sells molecular diagnostic systems for bio-threat detection and rapid medical testing.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.